Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
File(s)10.1007%2Fs10549-017-4633-6.pdf (759.6 KB)
Published version
Author(s)
Type
Journal Article
Abstract
In the original publication, Fig. 1 depicting the blot for EP300 in CAL51 cells (Fig. 1c) was unintentionally duplicated with that from MDA-MB-231 cells (Fig. 1d). The new figure given in this erratum depicts the correct EP300 blot in Fig. 1c.
Date Issued
2018-01-05
Date Acceptance
2017-03-13
Citation
Breast Cancer Research and Treatment, 2018, 167 (2), pp.605-606
ISSN
0167-6806
Publisher
Springer Verlag
Start Page
605
End Page
606
Journal / Book Title
Breast Cancer Research and Treatment
Volume
167
Issue
2
Copyright Statement
© Springer Science+Business Media, LLC, part of Springer Nature 2018.
Sponsor
Breast Cancer Research Trust
Identifier
PII: 10.1007/s10549-017-4633-6
Grant Number
PC2889BCRT
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status
Published